Ying-Hsu Chang

Ying-Hsu Chang

Auto-generated profile, based on publicly available information

Ying-Hsu Chang

Department of Medicine, Chang Gung University, Taoyuan, Taiwan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2018 in Journal of Advanced Nursing
Verified
Journal Article
Closed access
PDF file
CCChing‐Hui Chien
Ching‐Hui Chien
CCChengkeng Chuang
Chengkeng Chuang
KLKuan Liu
Kuan Liu
Jacob See-Tong Pang(Feng)Jacob See-Tong Pang(Feng)
Jacob See-Tong Pang(Feng)
CWChun-Te Wu
Chun-Te Wu
YCYing‐Hsu Chang
Ying‐Hsu Chang

21 July 2022 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
CLChung-Lin Lee
Chung-Lin Lee
YCYing-Hsu Chang
Ying-Hsu Chang
CLChung-Yi Liu
Chung-Yi Liu
MHMing Li Hsieh
Ming Li Hsieh
LHLiang-Kang Huang
Liang-Kang Huang
ISI Hung Shao
I Hung Shao
Lee CL, et al. Investig Clin Urol. 2022 Sep;63(5):546-553. https://doi.org/10.4111/icu.20210450

1 September 2013 in Urological Science
Verified
Journal Article
Open access
YTYu-Lun Tsai
Yu-Lun Tsai
PHPo-Fan Hsieh
Po-Fan Hsieh
WLWei-Yu Lin
Wei-Yu Lin
HSHsin-Hao Su
Hsin-Hao Su
CCChengkeng Chuang
Chengkeng Chuang
Jacob See-Tong Pang(Feng)Jacob See-Tong Pang(Feng)
Jacob See-Tong Pang(Feng)
ObjectiveTo assess the clinical characteristics, prognostic factors, and treatment outcomes of primary testicular lymphoma (PTL).Materials and MethodsWe reviewed the medical records of PTL patients diagnosed between January 2000 and May 2012 at four hospitals in Taiwan. The following data were collected and analyzed: patient age at diagnosis, B symptoms (fever, night sweats, and/or weight loss), tumor localization (diffuse or testis alone), tumor site (left, right, or bilateral), stage of disease, histological pattern, International Prognostic Index, treatment method and outcome, relapse, and survival time. Kaplan–Meier curves were constructed to assess the effects of various factors on patient survival.ResultsThirty patients with PTL were included in this study. The median age at diagnosis was 62.5 years (range: 19–89 years) and median overall survival (OS) was 44 months. The majority of the patients had unilateral lymphoma, stage I/II disease, and diffuse large B-cell lymphoma. An absence of B symptoms, limited disease stage, lymphoma localized to testis only, and orchidectomy were considered to be significantly favorable prognostic factors of OS (p < 0.05). The PTL treatment regimen varied among patients and included orchidectomy, chemotherapy, and/or radiotherapy. Interestingly, although 50% patients achieved complete remission (CR) post-treatment, relapse was observed in 42% patients during the follow-up period. Nonetheless, patients who initially underwent orchidectomy appeared to have a significantly better survival rate, whereas chemotherapy proved more advantageous for those with the diffuse-type PTL.ConclusionPTL is characterized by unique clinical features and prognostic factors. Despite differing treatment regimens, 50% of patients achieved CR. Patients with testicular localization who underwent orchidectomy may achieve better outcomes, whereas chemotherapy proved to be beneficial in those with diffuse-type PTL